Login

Nowrousian, Mohammad Resa

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Nowrousian, Mohammad Resa - Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology, ebook

175,40€

Ebook, PDF with Adobe DRM
ISBN: 9783211694596
DRM Restrictions

PrintingNot allowed
Copy to clipboardNot allowed

Table of contents

1. Physiology of erythropoiesis
Ugo Testa

2. Biology of EPO and EPO-receptor
Catherine Lacombe, P. Mayeux

3. The role of erythropoietin receptor expression on tumor cells
Joachim Fandrey

4. Problems associated with erythropoietin receptor determination on tumor cells
Anders Österborg

5. Definition, classification and characterization of anemia in cancer
M. R. Nowrousian

6. Pathophysiology of anemia in cancer
M. R. Nowrousian

7. Prevalence and incidence of anemia and risk factors for anemia in patients with cancer
Heinz Ludwig

8. Significance of anemia in cancer chemotherapy
M. R. Nowrousian

9. Incidence and impact of anemia in radiation oncology
Jürgen Dunst, M. Molls

10. Relationship between hemoglobin levels and tumor oxygenation
Peter Vaupel, Arnulf Mayer, Michael Höckel

11. Tumor hypoxia and therapeutic resistance
Peter Vaupel, Michael Höckel

12. Symptoms of anemia
Robert Pirker

13. Impact of anemia and red blood cell transfusion on organ function
M. R. Nowrousian

14. Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients
Zeeshan Butt, David Cella

15. When to use red blood cell transfusions in cancer patients with solid tumours?
Jayin K. Jacob, Peter J. Barrett-Lee

16. Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations
Wolfgang Jelkmann

17. Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma
Anders Österborg

18. rhEPO in anemic patients with solid tumors and chemotherapy — efficacy and safety
M. R. Nowrousian

19. Early intervention with recombinant human erythropoietin for chemotherapy-induced anemia
Gary H. Lyman, John Glaspy

20. Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia
Eva Hellström-Lindberg

21. Prediction of response to rhEPO in the anemia of cancer
Yves Beguin, Gaetan Straelen

22. rhEPO in hematopoietic stem cell transplantation
Gaetan Straelen, Yves Beguin

23. Treatment of anemia with rhEPO in radiation oncology
Jürgen Dunst

24. Recombinant human erythropoietin in pediatric oncology
Caroline Hastings, James Feusner

25. rhEPO in surgical oncology
Magali J. Fontaine, Lawrence T. Goodnough

26. Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy
Lawrence T. Goodnough

27. Are there risks for use of iron in cancer patients?
Pere Gascón

28. Metabolic and physiologic effects of rhEPO in anemic cancer patients
Kent Lundholm, Peter Daneryd

29. Effects of rhEPO on quality of life in anemic cancer patients
Simon Chowdhury, James F. Spicer, Peter G. Harper

30. Thrombosis during therapy with erythropoiesis stimulating agents in cancer
John Glaspy

31. The effect of rhEPO on survival in anemic cancer patients
Tim J. Littlewood

32.
From bench to bedside: Neuroprotective effects of erythropoietin
Hannelore Ehrenreich, Claudia Bartels

33. rhEPO in patients with anemia and congestive heart failure
Donald S. Silverberg, Dov Wexler, Adrian Iaina, S. Steinbruch, Y. Wollman, Doron Schwartz

34. Cost-effectiveness of treating cancer anaemia
Paul Cornes

Keywords: Medicine & Public Health, Oncology, Radiotherapy, Hematology, Surgery, Pharmacology/Toxicology, Blood Transfusion Medicine

Author(s)
Publisher
Springer
Publication year
2008
Language
en
Edition
2
Page amount
884 pages
Category
Medicine, Health Care, Mode
Format
Ebook
eISBN (PDF)
9783211694596

Similar titles